NCT06511973View on ClinicalTrials.gov

A Study to Learn About Whether BAYH006689 Causes Skin Irritation When Applied as a Topical Gel in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 23, 2024

Primary Completion Date

August 20, 2024

Study Completion Date

August 20, 2024

Conditions
PainHealthy Volunteers
Interventions
DRUG

Naproxen (BAYH006689)

BAYH006689 gel will be dispensed directly on the patch

DRUG

Placebo Gel

Placebo gel will be dispensed directly on the patch

DRUG

A solution of 0.9% Saline

0.9% Saline will be dispensed directly on the patch

DRUG

A solution of 0.2% SLS

0.2% SLS will be dispensed directly on the patch.

Trial Locations (1)

07410

TKL Research, Inc., Fair Lawn

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY